Concepedia

SHINJI MASUYOSHI

SM

Statistics

Publications

19

Citations

353

H-Index

13

Active since

1980

Affiliations

Bristol-Myers Squibb (Japan)(Current)

Bristol-Myers Squibb (Germany)

Gunma University

Toho University

SHINJI MASUYOSHI is an author at Bristol-Myers Squibb (Japan) specializing in cephalosporin therapy, life sciences, and microbiology.

Publications per year

1980–1993

19

Publications

19

In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative

Masatoshi Kakushima, SHINJI MASUYOSHI, Minoru Hirano et al. · Antimicrobial Agents and Chemotherapy · 1991 · 40 citations · Full text

, , +17

Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.

Masaki Hiraoka, SHINJI MASUYOSHI, Susumu Mitsuhashi et al. · The Journal of Antibiotics · 1988 · 37 citations · Full text

, , +14

In vitro antimicrobial activity of cefotaxime, a new cephalosporin

SHINJI MASUYOSHI, S Arai, M. Miyamoto et al. · Antimicrobial Agents and Chemotherapy · 1980 · 28 citations · Full text

, , +11

BU-4794F, a new .BETA.-1,3-glucan synthase inhibitor.

Mika Aoki, Tsutomu Andoh, Tomokazu Ueki et al. · The Journal of Antibiotics · 1993 · 28 citations · Full text

, , +4

In vitro and in vivo antifungal activities of BMS-181184.

TOSHIKAZU OKI, Masatoshi Kakushima, Minoru Hirano et al. · The Journal of Antibiotics · 1992 · 27 citations · Full text

, , +10

1–5 of 19